HCPLive

Top Medical News Today

Q&A With Maddalena Lettino From Humanitas Research Hospital: Emergency Room Equality and Managing Costs
Not all emergency rooms are created equal, but if hospitals work together patients can still get the care they need even if it means going to another institution. Ensuring patients can afford the care they receive is also a key component to this discussion.
In an emergency room doctors sometimes only have a matter of moments to make the best diagnosis for a patient. Having the tools to make those calls is important in keeping their patients healthy and alive.
While the treatment of atrial fibrillation has made many advancements in recent years there is still much more work to be done. As with other areas of medicine this includes individualized approaches to care.
At the annual ESC Congress in London there were many key studies presented. Some of them could provide information that doctors can put into practice as soon as they return to the office.
Atrial fibrillation is a common condition cardiologists face on a regular basis. How best to treat those patients is an area still being worked on in the field and in practices around the world.
The US Food and Drug administration today issued a warning that the type 2 diabetes medicines sitagliptin (Januvia/Merck) linagliptin (Tradjenta/BI), and alogliptin (Nesina/Takeda) “may cause joint pain that can be severe and disabling.”
Ebola can persist in wastewater, plastic, and steel and the virus has even gone undetected in a blood test. But how many physicians are actually prepared to properly assess a patient with a potential case of the deadly disease? A team from the Massachusetts General Hospital (MGH) found that physicians least likely to encounter patients with Ebola were more likely to use excessive approaches.
Fred Lublin, MD, discusses the molecular, immunologic, other treatments strategies being assessed for progressive multiple sclerosis.
A long-term study of alemtuzumab for treatment of Behçet disease (BD) yields promising evidence that the monoclonal antibody can successfully treat refractory and relapsing courses of the disease.

Features

Resources for Your Patients

Click here for the latest hepatitis C news and updates for patients

Most Popular

Recent Published Journal

$vacMongoViewPlus$ $vAR$